Gastrointestinal problems in the immunosuppressed patient

Archives of Disease in Childhood

Volumn 78, Issue 1, 1998, Pages 5-8

  Aggarwal, Vyom ^a   Williams, M D ^b   Beath, S V ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUSULFAN; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; STEROID; TACROLIMUS;

ARTICLE; CLINICAL FEATURE; DIARRHEA; ELECTRON MICROSCOPY; ENDOSCOPY; FECES CULTURE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE MUCOSA PERMEABILITY; LIVER FUNCTION TEST; MUCOSA INFLAMMATION; NUTRITIONAL INTOLERANCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCINTISCANNING; STOMACH ACID SECRETION;

EID: 0031956570     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.78.1.5     Document Type: Article

References (32)

1. Dobbins WO. Gut immunophysiology: a gastroenterologist's view with emphasis on pathophysiology. Am J Physiol 1982;242:G1-8.
2. Udall J. Immunologic aspects of gut function. In: Walker WA, Watkins JB, eds. Nutrition in pediatrics; basic science and clinical aspects. Boston: Little, Brown, 1985:301.
3. Webster ADB. Immunodeficiency and gut. Balliere's clinical gastroenterology 1987;1:547-65.
4. Papadopoulou A, Lloyd DR, Williams MD, et al. Gastrointestinal and nutritional sequelae of bone marrow transplantation. Arch Dis Child 1996;75: 208-13.
5. Engelhard D, Marks MI, Good RA. Infections in bone marrow transplant recipients. J Pediatr 1986;108:335-43.
6. Hooks MA. Tacrolimus, a new immunosuppressant: a review of the literature. Ann Pharmacother 1994;28:501-11.
7. Sokal EM, Caragiozoglou T, Lamy M, et al. Epstein-Barr virus serology and Epstein-Barr virus-associated lympho-proliferative disorders in pediatric liver transplant recipients. Transplantation 1993;56:1394-8.
8. Teitelbaum DH, Sonnino RE, Harmel RP Jr. Loss of intestinal integrity following small bowel transplant rejection in the rat. Transplant Proc 1996;28: 2547-8.
9. Fernandez Banares F, Villa S, Esteve M, et al. Acute effects of abdominopelvic irradiation on the oro-cecal transit time, its relation to clinical symptoms, and bile salt and lactose malabsorption. Am J Gastroenterol 1991;86:1771-7.
10. 2 antagonists and antibiotics and gastric surgery as risk factors for salmonella infection. BMJ 1994;308:176.
11. Doe WF. Immunodeficiency and the gastrointestinal tract. Clin Gastroenterol 1983;12:839-53.
12. Madsen KL, Yanchar NL, Sigalet DL, et al. FK 506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterology 1995; 109:107-14.
13. Mainous M, Dazhong X, Qi L, et al. Oral TPN induced bacterial translocation and impaired immune defenses are reversed by refeeding. Surgery 1991;110:277-84.
14. Stringer MD, Puntis JWL. Short bowel syndrome. Arch Dis Child 1995;73: 170-3.
15. Weisdorf SA, Salari JA, Longsdorf NKC, et al. Graft versus host disease of the intestine: a protein loosing enteropathy characterized by fecal alpha 1 antitrypsin. Gastroenterology 1983;85: 1076-81.
16. Nalesnik MA, Starzl TE. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Trasplant Sci 1994;4:61-79.
17. Opelz G, Henderson R. Incidence of non Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993;342:1514-6.
18. Shulman HM, Fisher LB, Schoch HG, et al. Veno-occlusive disease after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994;19:1171-81.
19. Green ES, Parker NE, Gellert AR, et al. Campylobacter infection mimicking Crohn's disease in an immunodeficient patient. BMJ 1984;289:159-60.
20. Cox GJ, Matsui SM, Lo RS, et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology 1994;107: 1398-1407.
21. Cello JP, Grendell JH, Bausk P, et al. Effect of octreotide on refractory AIDS associated diarrhea. A prospective, multicenter clinical trial. Ann Intern Med 1991;115:705-10.
22. Donaldson SS, Jundt S, Ricour C, et al. Radiation enteritis in children. Cancer 1975;35:1167-78.
23. Kaur S, Cooper G, Fakult S, et al. Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation. Dig Dis Sci 1996;41:598-603.
24. Benoit G, Moukarzel M, Verdelli G, et al. Gastrointestinal complications in renal transplantation. Transplant Int 1993;6:45-9.
25. Ianco G, Carroccio A, Cavatgio F, et al. Steatocrit test: normal range and physiological variations in infants. J Pediatr Gastroenterol Nutr 1990;11:53-7.
26. Appleton AL, Sviland L, Pearson ADJ, et al. The need for endoscopic biopsy in diagnosis of upper gastrointestinal graft versus host disease. J Pediatr Gastroenterol Nutr 1993;16:183-5.
27. Haron E, Feld R, Tuffnell P, et al. Hepatic candidiasis: an increasing problem in immunocompromised patients. Am J Med 1987;83:17-26.
28. Ascher NL, Ahrenholtz RL, Simmons RL, et al. Indium 111 autologous tagged leukocytes in the diagnosis of intraperitoneal sepsis. Arch Surg 1979;114:386-92.
29. Pamilli G, Laffaroli RV, Capuarno G, et al. Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy. Cancer Treat Rep 1982; 66:1435-6.
30. Losonsky GA, Johnson JP, Winkelstein JA, et al. Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis. A pharmacokinetic and functional analysis. J Clin Invest 1985; 76:2362-7.
31. Balisteri WF. Bile acid therapy in pediatric hepatobiliary disease: the role of ursodeoxycholic acid. J Pediatr Gastroenterol Nutr 1997;24:573-89.
32. Tasaki T, Ohto H, Abe R. Prevention of post transfusion graft versus host disease. Fukushima J Med Sci 1993;39:109-11.